Skip to main content

Aclaris Therapeutics, Inc.

ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001557746

No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Aclaris Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
110
−20 vs. Q4 2021
Shares held
59.3M
+3.52M (+6.3%) vs. Q4 2021
Total value
$1.02B
+$210.9M (+26.0%) vs. Q4 2021
New holders
10
37 more added
Sold out
30
43 more reduced

3 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 110 institutions
Q1 2021: 97 institutionsQ2 2021: 128 institutionsQ3 2021: 126 institutionsQ4 2021: 133 institutionsQ1 2022: 110 institutionsQ2 2022: 115 institutionsQ3 2022: 127 institutionsQ4 2022: 128 institutionsQ1 2023: 149 institutionsQ2 2023: 133 institutionsQ3 2023: 138 institutionsQ4 2023: 107 institutionsQ1 2024: 98 institutionsQ2 2024: 98 institutionsQ3 2024: 81 institutionsQ4 2024: 98 institutionsQ1 2025: 109 institutionsQ2 2025: 96 institutionsQ3 2025: 103 institutionsQ4 2025: 122 institutionsQ1 2026: 136 institutionsQ2 2026: 148 institutions
Value heldQ1 2022: $1.02B
Q1 2021: $1.14BQ2 2021: $983.4MQ3 2021: $1.02BQ4 2021: $814.9MQ1 2022: $1.02BQ2 2022: $883.3MQ3 2022: $1.00BQ4 2022: $1.04BQ1 2023: $579.3MQ2 2023: $737.2MQ3 2023: $480.0MQ4 2023: $61.4MQ1 2024: $67.5MQ2 2024: $58.1MQ3 2024: $58.5MQ4 2024: $217.0MQ1 2025: $143.8MQ2 2025: $130.4MQ3 2025: $162.8MQ4 2025: $252.1MQ1 2026: $409.4MQ2 2026: $630.0M
Institutions holding ACRS and their total value by quarter
QuarterHoldersValue
Q2 2026148$630.0M
Q1 2026136$409.4M
Q4 2025122$252.1M
Q3 2025103$162.8M
Q2 202596$130.4M
Q1 2025109$143.8M
Q4 202498$217.0M
Q3 202481$58.5M
Q2 202498$58.1M
Q1 202498$67.5M
Q4 2023107$61.4M
Q3 2023138$480.0M
Q2 2023133$737.2M
Q1 2023149$579.3M
Q4 2022128$1.04B
Q3 2022127$1.00B
Q2 2022115$883.3M
Q1 2022110$1.02B
Q4 2021133$814.9M
Q3 2021126$1.02B
Q2 2021128$983.4M
Q1 202197$1.14B

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding ACRS in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Point72 Asset Management, L.P.2,277,100$39.3M0.17%+1,634,200+254.2%Added
Commodore Capital LP2,314,648$39.9M8.91%−357,698−13.4%Reduced
Vanguard Group Inc2,728,820$47.0M0.00%+10,713+0.4%Added
Foresite Capital Management IV, LLC2,899,034$50.0M13.98%−500,000−14.7%Reduced
Rock Springs Capital Management LP3,865,034$66.6M1.68%+3,687+0.1%Added
BVF Inc3,976,543$68.6M2.74%+2,280,639+134.5%Added
BlackRock Inc.3,987,107$68.7M0.00%−91,768−2.2%Reduced
VR Adviser, LLC4,563,962$78.7M12.75%00.0%Unchanged
Wellington Management Group LLP5,730,253$98.8M0.02%+190,985+3.4%Added
IFP Advisors, Inc5––00.0%Unchanged
Cormorant Asset Management, LP0$00.00%−900,000−100.0%Sold out
Frazier Management LLC0$00.00%−408,329−100.0%Sold out
Darwin Global Management, Ltd.0$00.00%−216,143−100.0%Sold out
Hamilton Lane Advisors LLC0$00.00%−97,550−100.0%Sold out
Tri Locum Partners LP0$00.00%−55,433−100.0%Sold out
Pura Vida Investments, LLC0$00.00%−48,266−100.0%Sold out
Franklin Resources Inc0$00.00%−41,994−100.0%Sold out
Jump Financial, LLC0$00.00%−32,000−100.0%Sold out
Jane Street Group, LLC0$00.00%−31,228−100.0%Sold out
Sender Co & Partners, Inc.0$00.00%−30,132−100.0%Sold out
Engineers Gate Manager LP0$00.00%−27,453−100.0%Sold out
Martingale Asset Management L P0$00.00%−23,702−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−22,864−100.0%Sold out
Victory Capital Management Inc0$00.00%−22,650−100.0%Sold out
Alpine Global Management, LLC0$00.00%−20,528−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−19,368−100.0%Sold out
Old Mission Capital LLC0$00.00%−15,663−100.0%Sold out
Trexquant Investment LP0$00.00%−14,587−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−13,873−100.0%Sold out
SG Americas Securities, LLC0$00.00%−13,679−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−13,300−100.0%Sold out
Nomura Holdings Inc0$00.00%−13,068−100.0%Sold out
Two Sigma Investments, LP0$00.00%−13,044−100.0%Sold out
Blair William & Co0$00.00%−12,800−100.0%Sold out
Cherry Creek Investment Advisors, Inc.0$00.00%−11,440−100.0%Sold out
Boulder Hill Capital Management LP0$00.00%−11,200−100.0%Sold out
Walleye Capital LLC0$00.00%−10,341−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−1,784−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−309−100.0%Sold out
Truvestments Capital LLC0$00.00%−150−100.0%Sold out
Asymmetry Capital Management, L.P.––––Not filed
AlphaCentric Advisors LLC––––Not filed
Harbour Investments, Inc.––––Not filed